Literature DB >> 25302653

A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism.

Matthew J Lawrence1, Ahmed Sabra, Gavin Mills, Suresh G Pillai, Wendy Abdullah, Karl Hawkins, Roger H K Morris, Simon J Davidson, Lindsay A D'Silva, Daniel J Curtis, Martin R Brown, John W Weisel, Phylip R Williams, Phillip A Evans.   

Abstract

This study compared patients with venous thromboembolism (VTE) to non-VTE patients using a biomarker of clot microstructure (df ) and clot formation time (TGP ). df was the only marker that identified a significant difference (P < 0·001) between the VTE (n = 60) and non-VTE cohorts (n = 69). The 'abnormal' clot microstructures in the VTE patients suggests either inadequate response to anticoagulant therapy or the presence of a procoagulant state not detected by other markers of coagulation (i.e., International Normalized Ratio). Furthermore, elevated values of df in first time VTE patients who later develop a secondary event indicates that df may identify those at risk of recurrence.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  anticoagulation; blood coagulation; haemostasis; venous thrombosis; warfarin

Mesh:

Substances:

Year:  2014        PMID: 25302653     DOI: 10.1111/bjh.13173

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Hemostatic responses to exercise, dehydration, and simulated bleeding in heat-stressed humans.

Authors:  Matthew A Borgman; Morten Zaar; James K Aden; Zachary J Schlader; Daniel Gagnon; Eric Rivas; Jena Kern; Natalie J Koons; Victor A Convertino; Andrew P Cap; Craig Crandall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-09-19       Impact factor: 3.619

Review 2.  Fibrin Formation, Structure and Properties.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Subcell Biochem       Date:  2017

Review 3.  Fibrin mechanical properties and their structural origins.

Authors:  Rustem I Litvinov; John W Weisel
Journal:  Matrix Biol       Date:  2016-08-20       Impact factor: 11.583

4.  The changes in clot microstructure in patients with ischaemic stroke and the effects of therapeutic intervention: a prospective observational study.

Authors:  Sophia N Stanford; Ahmed Sabra; Lindsay D'Silva; Matthew Lawrence; Roger H K Morris; Sharon Storton; Martyn Rowan Brown; Vanessa Evans; Karl Hawkins; Phylip Rhodri Williams; Simon J Davidson; Mushtaq Wani; John F Potter; Phillip A Evans
Journal:  BMC Neurol       Date:  2015-03-15       Impact factor: 2.474

5.  Effects of unidirectional flow shear stresses on the formation, fractal microstructure and rigidity of incipient whole blood clots and fibrin gels.

Authors:  N Badiei; A M Sowedan; D J Curtis; M R Brown; M J Lawrence; A I Campbell; A Sabra; P A Evans; J W Weisel; I N Chernysh; C Nagaswami; P R Williams; K Hawkins
Journal:  Clin Hemorheol Microcirc       Date:  2015       Impact factor: 2.375

6.  Polyphosphate delays fibrin polymerisation and alters the mechanical properties of the fibrin network.

Authors:  Claire S Whyte; Irina N Chernysh; Marco M Domingues; Simon Connell; John W Weisel; Robert A S Ariens; Nicola J Mutch
Journal:  Thromb Haemost       Date:  2016-08-25       Impact factor: 5.249

7.  Characterisation of clot microstructure properties in stable coronary artery disease.

Authors:  Ahmed Sabra; Matthew James Lawrence; Robert Aubrey; Daniel Obaid; Alexander Chase; Dave Smith; Phillip Thomas; Sharon Storton; Gareth R Davies; Karl Hawkins; Phylip Rhodri Williams; Keith Morris; Phillip Adrian Evans
Journal:  Open Heart       Date:  2017-06-23

8.  Comparison of antithrombin-dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots.

Authors:  Stella Salta; Loula Papageorgiou; Annette K Larsen; Patrick Van Dreden; Claire Soulier; Dennis V Cokkinos; Ismail Elalamy; Grigoris T Gerotziafas
Journal:  Res Pract Thromb Haemost       Date:  2018-07-17

9.  The effects of apixaban on clot characteristics in atrial fibrillation: A novel pharmacodynamic biomarker.

Authors:  Matthew J Lawrence; Vanessa Evans; Janet Whitley; Suresh Pillai; Phylip R Williams; James Coulson; Manju Krishnan; Peter Slade; Kieron Power; Roger H K Morris; Phillip A Evans
Journal:  Pharmacol Res Perspect       Date:  2022-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.